Literature DB >> 10889794

Obesity and the metabolic syndrome: the San Antonio Heart Study.

S M Haffner1.   

Abstract

Obesity, especially visceral adiposity, is a major determinant of the development of type 2 diabetes. Both visceral adiposity and insulin resistance are strongly related to cardiovascular risk factors in diabetic and non-diabetic subjects. One of the areas where the correlation between visceral fat (upper body adiposity) and cardiovascular risk is most apparent is the prediabetic state. We have recently shown that only prediabetic subjects (those who later develop type 2 diabetes) who are insulin resistant and with upper body adiposity have increased triglycerides, decreased HDL cholesterol and high blood pressure.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10889794     DOI: 10.1017/s0007114500000970

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  16 in total

Review 1.  Does Upper Extremity Training Influence Body Composition after Spinal Cord Injury?

Authors:  Justin A Fisher; Meredith A McNelis; Ashraf S Gorgey; David R Dolbow; Lance L Goetz
Journal:  Aging Dis       Date:  2015-08-01       Impact factor: 6.745

2.  Higher risk for obesity among Mexican-American and Mexican immigrant children and adolescents than among peers in Mexico.

Authors:  María A Hernández-Valero; L Patricia Bustamante-Montes; Mike Hernández; Elizabeth Halley-Castillo; Anna V Wilkinson; Melissa L Bondy; Norma Olvera
Journal:  J Immigr Minor Health       Date:  2012-08

3.  Early pre-diabetic state alters adaptation of myocardial glucose metabolism during ischemia in rats.

Authors:  Sandrine Morel; Corinne Berthonneche; Stéphane Tanguy; Marie-Claire Toufektsian; Pascale Perret; Catherine Ghezzi; Joël de Leiris; François Boucher
Journal:  Mol Cell Biochem       Date:  2005-04       Impact factor: 3.396

4.  Implementation of a lifestyle program in primary care by nurse practitioners.

Authors:  Robin Whittemore; Gail D'Eramo Melkus; Nanette Alexander; Stacie Zibel; Elizabeth Visone; Ulrike Muench; Elizabeth Magenheimer; Stephanie Wilborne
Journal:  J Am Acad Nurse Pract       Date:  2010-11-05

5.  A comparison of Mediterranean-style and MyPyramid diets on weight loss and inflammatory biomarkers in postpartum breastfeeding women.

Authors:  Nicole R Stendell-Hollis; Patricia A Thompson; Julie L West; Betsy C Wertheim; Cynthia A Thomson
Journal:  J Womens Health (Larchmt)       Date:  2012-12-31       Impact factor: 2.681

6.  Early cardiovascular changes occurring in diet-induced, obese insulin-resistant rats.

Authors:  Barbara Huisamen; Daneel Dietrich; Nicole Bezuidenhout; John Lopes; Brian Flepisi; Dee Blackhurst; Amanda Lochner
Journal:  Mol Cell Biochem       Date:  2012-05-26       Impact factor: 3.396

Review 7.  The genetics of obesity and the metabolic syndrome.

Authors:  Keri L Monda; Kari E North; Steven C Hunt; D C Rao; Michael A Province; Aldi T Kraja
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2010-06       Impact factor: 2.895

8.  Cardiometabolic risk clustering in spinal cord injury: results of exploratory factor analysis.

Authors:  Alexander Libin; Emily A Tinsley; Mark S Nash; Armando J Mendez; Patricia Burns; Matt Elrod; Larry F Hamm; Suzanne L Groah
Journal:  Top Spinal Cord Inj Rehabil       Date:  2013

9.  Peripheral insulin resistance develops in transgenic rats overexpressing phosphoenolpyruvate carboxykinase in the kidney.

Authors:  B J Lamont; S Andrikopoulos; A Funkat; J Favaloro; J M Ye; E W Kraegen; K F Howlett; J D Zajac; J Proietto
Journal:  Diabetologia       Date:  2003-07-29       Impact factor: 10.122

10.  Serum concentrations of adiponectin, leptin, resistin, ghrelin and insulin and their association with obesity indices in obese normo- and hypertensive patients - pilot study.

Authors:  Mariusz Stępień; Rafał N Wlazeł; Marek Paradowski; Maciej Banach; Magdalena Rysz; Małgorzata Misztal; Jacek Rysz
Journal:  Arch Med Sci       Date:  2012-07-04       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.